Dopamine Inhibits Prolactin Secretion Stimulated by the Calcium Channel Agonist Bay-K-8644 through a Pertussis Toxin-Sensitive G Protein in Anterior Pituitary Cells*
- 1 July 1988
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 123 (1), 406-412
- https://doi.org/10.1210/endo-123-1-406
Abstract
In primary culture of anterior pituitary cells, BAY-K-8644, a calcium channel agonist, stimulated PRL secretion by 83% with EC50 of 18 nM. This effect was blocked by nifedipine, a calcium channel antagonist. The stimulations of PRL secretion induced by potassium (50 nM) and BAY-K-8644 were additive. Dopamine inhibited basal as well as BAY-K-8644-stimulated PRL secretion by 64% and 75%, respectively, and with respective EC50 values of 4.5 and 0.6 nM. In the presence of 50 mM K+, dopamine only partially blocks the dose-dependent stimulation of PRL secretion induced by the calcium channel agonist. The inhibitory dopamine effect was blocked by (+)butaclamol, a specific dopamine receptor antagonist. The dopamine response was also blocked by 1-sulpiride, a specific dopamine D2 receptor antagonist, and mimicked by RU 24926, a specific dopamine D2 receptor agonist, suggesting that the dopamine effect on BAY-K-8644-stimulated PRL secretion was mediated through a D2 dopamine receptor. Although unknown, the mechanism by which dopamine inhibited the BAY-K-8644-stimulated PRL secretion involves a CTP binding protein sensitive to Bordetella pertussis toxin. In fact, the dopamine inhibition of PRL secretion induced by the calcium channel agonist was blocked by the pretreatment of cells with the toxin. These results suggest that dopamine D2 receptors in lactotroph cells modulate calcium influx through a GTP binding protein.This publication has 38 references indexed in Scilit:
- Physiological Concentrations of Dopamine Decrease Adenosine 3′,5′-Monophosphate Levels in Cultured Rat Anterior Pituitary Cells and Enriched Populations of Lactotrophs: Evidence for a Causal Relationship to Inhibition of Prolactin Release*Endocrinology, 1982
- Adenosine 35′5′-Monophosphate Derivatives Increase Prolactin Synthesis and Prolactin Messenger Ribonucleic Acid Levels in Ergocryptine-Treated Pituitary Cells*Endocrinology, 1982
- The Effect of Dopamine on Thyrotropin-Releasing Hormone-Induced Prolactin SecretionIn VitroM*Endocrinology, 1981
- Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary.Proceedings of the National Academy of Sciences, 1981
- Calcium Rather Than Cyclic AMP as the Physiological Intracellular Regulator of Prolactin ReleaseNeuroendocrinology, 1980
- Stimulation of in vitro Prolactin Release by Vasoactive Intestinal PeptideNeuroendocrinology, 1980
- [3H]Spiroperidol (Spiperone) Binding to a Putative Dopamine Receptor in Sheep and Steer Pituitary and Stalk Median Eminence*Endocrinology, 1979
- Multiple receptors for dopamineNature, 1979
- Dopaminergic receptors in the anterior pituitary gland. Correlation of [3H]dihydroergocryptine binding with the dopaminergic control of prolactin release.Journal of Biological Chemistry, 1978
- Action potentials occur in cells of the normal anterior pituitary gland and are stimulated by the hypophysiotropic peptide thyrotropin-releasing hormone.Proceedings of the National Academy of Sciences, 1977